Search Results - "Bequet, Monica"

Refine Results
  1. 1

    Oncogenes and tumor angiogenesis: The HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner by LOPEZ-OCEJO, Omar, VILORIA-PETIT, Alicia, BEQUET-ROMERO, Monica, MUKHOPADHYAY, Debabrata, RAK, Janusz, KERBEL, Robert S

    Published in Oncogene (21-09-2000)
    “…Like other types of pre-malignant lesions and carcinoma, angiogenesis is associated with high-grade cervical dysplasia and with invasive squamous carcinoma of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Potential mechanisms involved on how systemic IgG antibodies specific to vascular endothelial growth factor (VEGF) and induced by active immunotherapy decrease platelet derived free-VEGF by Sánchez Ramírez, Javier, Morera Díaz, Yanelys, Bequet-Romero, Mónica, Ayala Ávila, Marta

    Published in Platelets (Edinburgh) (03-10-2022)
    “…CIGB-247 is a vascular endothelial growth factor (VEGF)-based active immunotherapy and it is currently under investigation for cancer treatment. This specific…”
    Get full text
    Journal Article
  4. 4

    Does VEGF-targeted active immunotherapy induce complete abrogation of platelet VEGF levels? by Sánchez Ramírez, Javier, Bequet-Romero, Mónica, Morera Díaz, Yanelys, Hernández-Bernal, Francisco, Ayala Avila, Marta

    Published in BMC research notes (10-06-2019)
    “…Vascular endothelial growth factor (VEGF) is involved in physiological angiogenesis, but also is considered one of the key factors that promotes tumor…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice by BEQUET-ROMERO, Monica, AYALA, Marta, ACEVEDO, Boris E, GALBAN RODRIGUEZ, Ernesto, LOPEZ OCEJO, Omar, TORRENS, Isis, GAVILONDO, Jorge V

    Published in Angiogenesis (London) (01-03-2007)
    “…Passive immunotherapy against soluble pro-angiogenic factors and/or their receptors in endothelial cells has become a promising approach in cancer…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Biologically active vascular endothelial growth factor as a bacterial recombinant glutathione S-transferase fusion protein by Morera, Yanelys, Lamdan, Humberto, Bequet, Mónica, Ayala, Marta, Rojas, Gertrudis, Muñoz, Yasmiana, Gavilondo, Jorge V.

    Published in Biotechnology and applied biochemistry (01-04-2006)
    “…Human VEGF121 (vascular endothelial growth factor isoform 121) was produced as a recombinant fusion protein with GST (glutathione S‐transferase) in Escherichia…”
    Get full text
    Journal Article
  15. 15

    Specific active immunotherapy with the HEBERSaVax VEGF-based cancer vaccine: From bench to bedside by Morera-Díaz, Yanelys, Gavilondo, Jorge V., Bequet-Romero, Mónica, Sánchez Ramírez, Javier, Hernández-Bernal, Francisco, Selman-Housein, Katty-Hind, Perez, Lincidio, Ayala-Ávila, Marta

    Published in Seminars in oncology (01-01-2018)
    “…HEBERSaVax is a cancer therapeutic vaccine candidate based on the combination of a recombinant antigen representative of human vascular endothelial growth…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    A multivalent recombinant antibody fragment specific for carcinoembryonic antigen by Perez, Lincidio, Ayala, Marta, Pimentel, Gilmara, Bell, Hanssel, Canaán-Haden, Leonardo, Bequet, Mónica, González, Luis Javier, Miranda, Marlen, Ravelo, Rolando, Roque, Lourdes, Acevedo, Boris, Oliva, Juan P., Gavilondo, Jorge V.

    Published in Biotechnology and applied biochemistry (01-01-2006)
    “…In the present paper we report the development of a bivalent scFv (single‐chain Fv) antibody fragment, starting from a mouse mAb (monoclonal antibody) specific…”
    Get full text
    Journal Article
  19. 19

    CIGB-247: A VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumors by Bequet-Romero, Mónica, Morera, Yanelys, Ayala-Ávila, Marta, Ancizar, Julio, Soria, Yordanka, Blanco, Aracelys, Suárez-Alba, Jesús, Gavilondo, Jorge V

    Published in Vaccine (27-02-2012)
    “…Highlights ► Antimetastatic effects of a VEGF based active immunotherapy: CIGB-247. ► CIGB-247 is a cancer therapeutic, based on recombinant modified VEGF as…”
    Get full text
    Journal Article
  20. 20